Individualized Weight Loss
*Based on Ivim’s published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary.
Your Ivím GLP-1 ID Patient Journey
Here’s how it works:
What your individual program includes
Competitors
Medicine
ONLY
$850 value
coaching & community
$500 value
formulated supplements
Ivím Health App
What to Expect
Your Ivím GLP-1 ID Patient Journey
Understanding individualized compounded GLP-1 medications
Learn more about GLP-1s
-
Wegovy® Pill: How It Works, Side Effects & Oral vs Injectable
Needles have long been the primary path to GLP-1 therapy for weight loss. That reality excluded patients who couldn’t or wouldn’t self-inject, regardless of how much they might have benefited from treatment. While Rybelsus (oral semaglutide) has been available since 2019 for type 2 diabetes, no oral option existed specifically for obesity treatment […]
-
What to Know About Hair Loss on Weight Loss Medications Like Ozempic and Wegovy
A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss. While alarming, medical experts say this shedding is typically temporary and linked to rapid weight loss rather than the medications themselves. […]
-
Why Starting Your GLP-1 Weight Loss Journey Feels Different With Support
Starting something new can feel like standing at the edge of unfamiliar territory, and beginning a GLP-1 weight loss journey is no exception. You may have done your research, talked to friends, or scrolled through countless articles. But when the moment […]
*Based on Ivim’s published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary.
*Based on our internal data and individual patient outcomes may vary. This does not constitute a guarantee of specific results.
✝ These results include data from patients using both FDA-approved and compounded formulations.
Individualized virtual integrative medicine (IVIM): A clinical model for enhanced GLP-1 therapeutic outcomes



